CareCOPD - COPD Home Monitoring Study

Description

This is a pilot study to demonstrate early validation of objective home-monitoring of Chronic obstructive pulmonary disease (COPD) patients by combining accurate and relevant patient data of medication and lung function (lung impedance) through patient-facing devices.

Conditions

Chronic Obstructive Pulmonary Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a pilot study to demonstrate early validation of objective home-monitoring of Chronic obstructive pulmonary disease (COPD) patients by combining accurate and relevant patient data of medication and lung function (lung impedance) through patient-facing devices.

CareCOPD - Chronic Obstructive Pulmonary Disease (COPD) Home Monitoring for Early Exacerbation Detection

CareCOPD - COPD Home Monitoring Study

Condition
Chronic Obstructive Pulmonary Disease
Intervention / Treatment

-

Contacts and Locations

Ventura

Ventura County Medical Center, Ventura, California, United States, 93003

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Males and females over the age of 40 years.
  • * physician-diagnosed COPD classified as GOLD 2-3, C-D for at least 1 year.
  • * Using rescue medications at home delivered by a metered-dose inhaler or MDI.
  • * Speak, read, and understand English.
  • * Able to understand study requirements and comply with study procedures.
  • * Ability to operate a smartphone or tablet (for questionnaire and symptoms input).
  • * Physically disabled such that they are incapable of performing forced oscillometry test (for airway impedance measurement)
  • * Physically disabled such that they are incapable of using metered-dose inhalers.
  • * Suffer from any visual, hearing, or cognitive impairment that cannot be corrected enough to operate the CareCOPD devices properly. Mild/moderate vision loss and mild hearing loss may be included with appropriate corrective measures that do not affect the device usage.
  • * Suffering from serious uncontrolled medical conditions that may interfere with study conduct.
  • * Continuous home Oxygen use for greater than 16 hours/day.
  • * Inability or unwillingness of the participant to give written informed consent.
  • * Individuals who are not yet adults (infants, children, teenagers)
  • * Pregnant women
  • * Prisoners

Ages Eligible for Study

40 Years to 100 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Cognita Labs LLC,

Study Record Dates

2026-07-31